Cargando…
Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults
BACKGROUND: We recently reported that CSF phosphorylated tau (p-Tau(181)) relative to Aβ(40) (CSF p-Tau/Aβ(40) ratio) was less noisy and increased associations with Alzheimer’s disease (AD) biomarkers compared to CSF p-Tau(181) alone. While elevations of CSF p-Tau/Aβ(40) can occur in amyloid-β (Aβ)...
Autores principales: | Guo, Tengfei, Landau, Susan M., Jagust, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520216/ https://www.ncbi.nlm.nih.gov/pubmed/34654465 http://dx.doi.org/10.1186/s13195-021-00913-5 |
Ejemplares similares
-
Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
por: Insel, Philip S., et al.
Publicado: (2017) -
Normalization of CSF pTau measurement by Aβ(40) improves its performance as a biomarker of Alzheimer’s disease
por: Guo, Tengfei, et al.
Publicado: (2020) -
Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease
por: Giorgio, Joseph, et al.
Publicado: (2020) -
Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline
por: Leal, Stephanie L, et al.
Publicado: (2017) -
Plasma β-amyloid in Alzheimer’s disease and vascular disease
por: Janelidze, Shorena, et al.
Publicado: (2016)